Evidence map›Paper›PMID 42490219›Full record

ArticleSTAR protocols2026

Protocol for generation of a 3D humanized lung-tumor-on-a-chip model of immune-hot and immune-cold microenvironments.

Sabrina Brito Añez, Sanne van Kesteren, Peter Carmeliet, Anna Rita Cantelmo, Patricia Yagüe, Jeffrey Kroon

Abstract read
In one paragraph

Article in STAR protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sabrina Brito AñezLaboratory of Angiogenesis and Vascular Metabolism, Department of Oncology and Leuven Cancer Institute (LKI), KU Leuven, VIB Center for Cancer Biology, VIB, 3000 Leuven, Belgium.
Sanne van KesterenAmsterdam Cardiovascular Sciences, Atherosclerosis & Aortic Disease, Amsterdam, the Netherlands; Amsterdam UMC Location University of Amsterdam, Department of Experimental Vascular Medicine, Meibergdreef 9, Amsterdam, the Netherlands.
Peter CarmelietLaboratory of Angiogenesis and Vascular Metabolism, Department of Oncology and Leuven Cancer Institute (LKI), KU Leuven, VIB Center for Cancer Biology, VIB, 3000 Leuven, Belgium; Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates.
Anna Rita CantelmoUniversité de Lille, Inserm, CHU Lille, Institute Pasteur de Lille, U1011-EGID, 59000 Lille, France.
Patricia YagüeLaboratory of Angiogenesis and Vascular Metabolism, Department of Oncology and Leuven Cancer Institute (LKI), KU Leuven, VIB Center for Cancer Biology, VIB, 3000 Leuven, Belgium. Electronic address: patricia.yagueesanz@kuleuven.be.
Jeffrey KroonAmsterdam Cardiovascular Sciences, Atherosclerosis & Aortic Disease, Amsterdam, the Netherlands; Amsterdam UMC Location University of Amsterdam, Department of Experimental Vascular Medicine, Meibergdreef 9, Amsterdam, the Netherlands. Electronic address: j.kroon@amsterdamumc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tumor microenvironment (TME) modulates immune responses and clinical outcomes. Here, we present a protocol to establish a fully humanized immune-hot and -cold lung TME using the Emulate organ-on-a-chip system by culturing human lung microvascular endothelial cells and human lung tumor cells. We describe steps for perfusing human peripheral blood mononuclear cells (PBMCs), visualizing immune cell recruitment, and analyzing immune infiltration across TME phenotypes through immunofluorescence, flow cytometry, or secretome analysis. This protocol can be adapted to model the TME in different cancer types.

Indexed as

CancerCell cultureFlow cytometryImmunology

Identifiers

PMID42490219
PMCPMC13425899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.